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ABSTRACT
At the cellular level, development progresses through successive regulatory states, each characterised by their specific gene expression profile. However, the molecular mechanisms regulating first the priming and then maintenance of gene expression within one developmental pathway are essentially unknown. The hematopoietic system represents a powerful experimental model to address these questions and here we have focused on a regulatory circuit playing a central role in myelopoiesis: the transcription factor PU.1, its target gene Colony-Stimulating-Factor 1 Receptor (Csf1r), and key upstream regulators such as RUNX1. We find that during ontogeny, chromatin unfolding precedes the establishment of active histone marks and the formation of stable transcription factor complexes at the Pu.1 locus and we show that chromatin remodelling 
INTRODUCTION
During development gene activation is regulated by specific transcription factors, which interact with chromatin remodelling and modification factors to establish active chromatin structures. This is also true for the hematopoietic system. All mature blood cell lineages originate from hematopoietic stem cells (HSCs), which have the capacity to selfrenew and differentiate. Lineage specification is regulated by a shift in balance of antagonistic transcription factors, which drive the expression of lineage appropriate genes and repress alternative lineage fates [1] [2] [3] . In order to direct differentiation into the distinct blood cell lineages at appropriate frequency, genes encoding hematopoietic regulators need to be expressed in a strictly controlled fashion both in terms of hierarchy and precise level of expression. If this hierarchy is altered by expression at an inappropriate developmental stage, differentiation is deregulated 4 and cells can be reprogrammed into alternate lineages 5, 6 or are subverted into leukemia.
Many hematopoietic lineage specific genes are first transcriptionally activated in
HSCs whereby transcription factors bind to their recognition sequences in a stable fashion and heritably maintain an active chromatin structure 7, 8 . Little is known about the order of events establishing this active chromatin state in development and how it is maintained in a lineage-specific fashion. To address this question in molecular detail, we studied a regulatory circuit that occupies a central role in myelopoiesis: the gene encoding for the transcription factor PU.1 and one of its targets, the Colony-StimulatingFactor 1 Receptor gene (Csf1r), together with upstream factors regulating their expression. The developmental regulation of both genes has been extensively studied.
Most transcription factors regulating their expression have been identified and important cis-regulatory elements and their chromatin structure have been characterized [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Pu.1 is essential for myelopoiesis 19, 20 . Its expression is switched on at the onset of hematopoietic development and is maintained during myelopoiesis and B-lymphopoiesis, but is downregulated in erythroid cells and T cells 21 . Overexpression of PU.1 in transgenic mice leads to erythroleukaemia 22 , and reduced levels of PU.1 cause myeloid leukaemia 15 .
PU.1 expression levels therefore need to be tightly regulated in development. Csf1r is absolutely required for macrophage differentiation 23 and its expression is crucially dependent on the prior expression of PU.1 9, 24 . Also Csf1r expression is tightly regulated.
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From Csf1r mRNA is expressed at low levels in HSCs, but high-level expression is only observed in committed macrophage precursor cells 9 . Both genes are targets for the transcription factor RUNX1. RUNX1 is absolutely required for definitive hematopoiesis as well as for Pu.1 and Csf1r expression, and thus for the establishment of myelopoiesis at later developmental stages 10, 25 . Interestingly, RUNX1 appears to be largely dispensable for hematopoietic development once stem cells have formed in the adult organism 26, 27 , indicating a fundamental difference in the molecular requirements for the establishment and the maintenance of the hematopoietic gene expression program. The molecular basis for this difference is unknown.
Using the differentiation of mouse embryonic stem (ES) cells as model we addressed these issues and performed an in-depth analysis of events in chromatin leading up to the transcriptional activation of Pu.1 and Csf1r during blood cell development and the molecular mechanisms regulating these processes. We focussed on the following fundamental questions of (i) which type of chromatin alterations were the first ones to mark Pu.1 and Csf1r for activation and (ii) whether RUNX1 was required for this initial chromatin activation. We also asked, (iii) whether RUNX1 primed chromatin by forming stable transcription factor complexes, (iv) whether there was a developmental window during which RUNX1 had to act and finally (v) whether RUNX1 was still needed once stable transcription factor complexes had formed on critical hematopoietic regulator genes. Our study shows that RUNX1 orchestrates blood-cell lineage specific chromatin priming at a much earlier developmental stage than previously thought. We also provide direct proof for the idea that once RUNX1 has initiated the expression of hematopoietic transcription factor genes, a stable transcription factor circuit is formed on these genes and active chromatin is maintained in a heritable fashion.
MATERIAL AND METHODS

Cell Isolation and Culture
The Bry-GFP ES cell line carries a GFP knocked into the brachyury locus 28 . These cells and all other lines described here were cultured and fractionated as described 28 was generated the same way, but V5-Dam was amplified from the pLgw V5-EcoDam and fused to RUNX1. Differentiation and induction of Flk1 + cells was done as described above for iRUNX1.
RAW264 macrophages and NIH3T3 fibroblasts were cultured as described in 9 .
Primary macrophages were grown from whole mouse bone marrow and isolation of the Lin -/Sca + /c-kit + and Common Myeloid Precursors (CMP) was performed as described in 11 .
Colony Assays
Flk1 + wild-type and iRUNX1 cells were plated into the blast colony media described previously 28 . After 4 days of culture cells were replated at 1x10 5 cells/ml in a methylcellulose media supporting the growth of myeloid hematopoietic progenitors (Stem cell technologies) and colonies were counted after 7 days.
DNA Methylation Analysis and DamId
Bisulfite treatment of genomic DNA was performed using EZ DNA Methylation Kit (Zymo Research). PCR primers were complementary to the upper DNA strand after
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From modification and two rounds of nested PCR were performed using primers listed in Table   S1 . Gel-purified products were ligated into pCR2.1 plasmid (Invitrogen) and 20 clones were sequenced.
Dam-methylation analysis of genomic DNA purified from induced iDam and iRUNX1-Dam cells was performed exactly as described 32 except that gene-specific primers were used to detect differential GATC methylation after the LM-PCR-step.
Primers used for both assays are depicted in Table S1 .
Chromatin Immunoprecipitation (ChIP) assays and Real-Time PCR Analysis
After sorting, cells were incubated for 2 h under embryoid body-forming conditions to allow recovery which did not change the expression of GFP/Bry and Flk-1.
Undifferentiated ES cells and sorted cell populations were then crosslinked using formaldehyde (1% final concentration), lysed and sonicated to obtain 0.5-1 kb fragments.
The chromatin was mixed with crosslinked and sonicated Drosophila DNA in a ratio of 1:4. Chromatin was immunoprecipitated using anti-H3K27me3 (Upstate, # 07-449), antiH3K9ac (Abcam 4441), anti-H3K4me3 (Abcam 8580) or anti-H3 (Abcam, # ab-1791-100) antibodies as described 33 . ChIp experiments detecting transcription factors were performed as described in 9 with the following antibodies: anti C/EBPβ (Santa Cruz, SC-150X), anti Fli-1 (SC-356X) and antiHA (H6908, Sigma). Precipitated DNA was quantified by real-time quantitative PCR as described 34 . Signals observed with the specific antibody were divided by the signals obtained from an input control and were additionally normalized against the signal obtained with the H3 antibody or against an internal control in case of transcription factor ChIps. Primers are listed in Table S1 .
Replication Timing
For replication timing analysis, ES cells and embryoid bodies were pulse labelled (30 min) with BrdU (50 mM, Sigma) before harvesting. BrdU-labelled ES cells and their derivatives were fixed with 70% cold ethanol, stained with propidium iodide, sorted according to DNA content into 6 consecutive cell cycle fractions (G1-S, S1, S2, S3, S4, G2-M) and newly replicated DNA purified using an anti-BrdU antibody (BD) as previously described 35 . Real-time PCR was performed for each fraction to determine the In vivo Footprinting Analysis.
DNaseI, MNase and DMS treatment of cells and naked DNA as well as Ligationmediated PCR (LMPCR) were performed exactly as described 36, 37 . Primers used for footprinting analyses are listed in Table S1 . Bands were quantified using QuantityOne™ software.
RNA Expression Analysis
Total RNA was extracted using Trizol (Invitrogen) and contaminating genomic DNA was removed by DNaseI treatment. 2 μ g of total RNA were used for cDNA synthesis, using oligo(dT)15-mer primer or random primers and MLLV reverse transcriptase followed by Real-time PCR with primers listed in Table S1 . Relative expression was calculated as a ratio to the GAPDH signal. For personal use only. on August 31, 2017. by guest www.bloodjournal.org From introduces single strand cuts at the surface of nucleosomes generating cleavage patterns that are defined by the rotational positioning of nucleosomes, transcription factor binding and chromatin folding. Under conditions of limited digestion, DNaseI can also be used to assay the general accessibility of chromatin in different cell types (which should not be confused with DNaseI hypersensitivity), since nucleosomal DNA can be masked by higher order chromatin structure 9, 17 . Another feature of DNaseI is that it can detect altered cleavage patterns caused by short-lived transcription factor DNA interactions 8 .
RESULTS
Pu
We compared ES cells, ES-cell derived cell populations and Pu.1/Csf1r
expressing primary macrophages with 3T3 cells where both genes are epigenetically silenced 8, 17 . The DNaseI accessibility analysis revealed striking differences in the degree of chromatin accessibility at the promoters of Pu.1 and Csf1r in the different cell types. As expected, DNaseI accessibility was low at both genes in 3T3 cells compared to macrophages, as indicated by weaker band intensities throughout the promoter regions ( Fig. 2A) Fig. S7 D) . This effect was specific for
Pu.1 since the absence of RUNX1 had no effect on DNaseI accessibility at the Oct4 promoter (Supplemental Fig. S7 E) . Figure 10 and data not shown). Binding levels were comparable to those at Runx1 distal promoter which is itself a target of RUNX1 52, 53 .
We next tested whether a short induction of iRUNX1 in Flk1 + cells in the absence of hematopoietic cell differentiation was sufficient to induce iRUNX1 binding and rescue chromatin remodelling. The induction of iRUNX1 by a 4 hour treatment with DOX in hemangioblasts at day 3.5 was not sufficient to switch on Pu.1 or Cebpa expression and did not alter expression of Fli1 (Fig. 4 and data not shown), but chromatin remodelling was restored (Fig. 4 C) . Also under these conditions no iRUNX1 binding to its target site Taken together, these experiments indicate that while RUNX1 is required for chromatin unfolding at Pu.1, it is unable to assemble stable transcription factor complexes on its target in hemangioblasts and only interacts transiently with its template.
RUNX1 is not required for the maintenance of active chromatin at Pu.1 and Csf1r
Using conditional gene targeting strategies it was shown that RUNX1 is required to establish the hematopoietic system, but is not essential to maintain it 26,27,57 . The molecular basis of this finding is unknown. To examine the role of RUNX1 in the maintenance of active chromatin at Pu.1, we made use of the fact that the DOXFor personal use only. on August 31, 2017. by guest www.bloodjournal.org From responsive promoter expressing RUNX1 was rapidly switched off after DOX removal 58 .
To this end, we sorted hemangioblasts from iRUNX1 ES cells, plated them in blast mix and induced with DOX after two days of culture. Wild type (wt) cells served as control.
DOX was removed after 12 hours and cells were cultured for 4 days in total, then were harvested to measure Runx1, Pu.1 and Csf1r mRNA levels and to plate them into methylcellulose cultures to form hematopoietic colonies. Fig. 6 shows that without DOX induction no Pu.1 or Csf1r mRNA was expressed and little or no definitive hematopoietic colonies were formed. DOX treatment did not influence colony formation in wt cells (data not shown). 24 hrs after DOX withdrawal, no Runx1 mRNA or RUNX1 protein could be detected (Fig. 6A, B) . RUNX1 induction was required to induce Pu.1 mRNA, but not for its sustenance after DOX withdrawal. This was also seen with C/EBP family members (Supplemental Fig. S11 ). Moreover, like in wt cultures (Supplemental Fig.   S7B ), Csf1r mRNA was induced with a delayed kinetics. Although colony numbers were reduced compared to wild-type cells where differentiation was continuous, myeloid cells had a normal morphology, demonstrating that a 12-hour pulse of DOX rescued definitive hematopoietic development which was then sustained for at least 9 days (Fig. 6 C and D) .
DMS in vivo footprinting and ChIP experiments demonstrated that RUNX1 was not
required to maintain the binding of all other factors at the 3'URE and the promoter after RUNX1 withdrawal ( Fig. 7 and data not shown). We noted that there was a weak, but reproducible protection of the RUNX1 binding site at the URE. Inspection of the expression of other RUNX1 family members indicated the presence of RUNX2 and RUNX3 mRNA (Supplemental Fig. S11 ). When overexpressed, these factors can indeed rescue hematopoietic development in RUNX1 knock-out ES cells 59 . However, both were also present in the absence of DOX, indicating that these proteins may be able to cooperate with other factors at the URE once these have been induced, but that at the levels at which they are expressed in hemangioblasts are unable to replace RUNX1 at early stages of hematopoietic development.
In summary, our experiments suggest that (i) RUNX1 is absolutely required to unfold chromatin at Pu.1 in hemangioblasts, (ii) that RUNX1 interacts with Pu.1 in a transient fashion, and (iii) that RUNX1 is required for the activation of Pu.1, Csf1r and
Cebpa transcription, but it is not essential once hematopoietic precursors have formed
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DISCUSSION
In this study we made a number of significant new observations. First, we show that chromatin activation at Pu.1 and Csf1r follows a clear hierarchy that is defined by a differential transcription factor dependency. Although RUNX1 binds to both loci 10, 60 , it is sufficient to initiate chromatin remodelling at Pu.1 at the onset of hematopoietic development, but not at Csf1r. In previous experiments examining Csf1r activation we demonstrated that at this gene chromatin unfolding is crucially dependent on the expression of high levels of PU.1 9 . We recently found that RUNX1 binding to Csf1r is also dependent on the presence of PU.1 (data not shown). This indicates that although RUNX1 is required to activate important hematopoietic regulator genes and thus generate hematopoietic cells in the first place, its priming activity is context dependent, ensuring that in the embryo Csf1r is not expressed outside the hematopoietic system.
Our second important result demonstrates that at Pu.1 chromatin unfolding and the selective demethylation of DNA precede the establishment of active histone marks.
Neither Pu.1 nor Csf1r carry significant levels of bivalent chromatin marks in ES cells or their immediate progeny, but instead are organized in DNaseI inaccessible chromatin and DNA is methylated. It is therefore likely that both genes have to remain firmly silenced until needed to ensure that blood cell development proceeds normally.
Another important result from this study is our finding that RUNX1 directly interacts with its target sequences in hemangioblasts but that this interaction is transient.
Experiments looking at the interaction of the unliganded estrogen receptor with chromatin demonstrated that incomplete factor complexes occupy their binding sites with a very short half-life and are often only detectable in synchronized cells 61 . Using a highaffinity antibody we could previously show that unstable protein -DNA interactions which could induce chromatin remodelling in a hit-and-run fashion do occur in precursor cell lines 34 and our experiments provide direct evidence that this is also the mechanism operating in the differentiation system described here. As outlined above, hemangioblasts express a number of transcription factors capable to bind to Pu.1, but none of them is able For personal use only. on August 31, 2017. by guest www.bloodjournal.org From our study defines a brief developmental window after which RUNX1 is no longer essential for hematopoietic differentiation and the activation of myeloid specific genes.
As outlined in Figure 7 C, we propose that this is due to the fact that RUNX1 is crucial for the initial chromatin remodelling at transcription factor genes that serve as master regulators for specific blood cell lineages. Our data suggest that once these transcription factors are expressed, stable transcription factor complexes are formed on these genes and active chromatin is maintained, meaning that an epigenetic memory for active gene expression is established. Once this has occurred, RUNX1 becomes less important and is only used in certain genomic contexts as one of many other transcription factors which in combination are necessary to efficiently maintain the hematopoietic transcriptional network. This could explain why RUNX1 is not generally essential for adult hematopoiesis 26, 27 , but has been shown to be necessary for maintaining normal blood cell development over time 63 , suggesting that its deletion impacts on the long-term stability of transcription factor complexes in a continuously replicating precursor cell population.
While our results are currently based on the detailed analysis of only a few genes, we believe that similar principles operate in the entire hematopoietic system and at many different developmental pathways. For personal use only. on August 31, 2017. by guest www.bloodjournal.org From genes has been described in 9, 67 . The relative importance of the different transcription factors is illustrated by thin and bold lines, respectively. 
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